ZYDUS LIFESCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 947.4 INR | -0.40% |
|
+2.74% | +37.46% |
| 04-26 | Weak March Quarter Earnings Weigh Down Indian Equities on Friday | MT |
| 04-26 | Zydus Lifesciences Gets US FDA's Final Approval for Generic Acne Cream | MT |
Chart calendar Zydus Lifesciences Limited
c0342.BCokEZGcTkeaT89ONQ4a7Y33bffGtsMAu3wXQdkKtDk.PWUVdqHFI2rLOKMpalQjuMCSXraL9ak1iT0nF6lJ4GNmGm4g-M8jGM94qA~bbc293bb05d91cb5414080df4f7fb56c
Upcoming events on Zydus Lifesciences Limited
Past events on Zydus Lifesciences Limited
| 05/03/2024 | Investor Meeting |
| 18/02/2024 | Kotak Chasing Growth Conference |
| 13/02/2024 | IIFL Enterprising India Global Investors Conference |
| 09/02/2024 10:00 | Q3 2024 Earnings Call |
| 09/02/2024 07:26 | Q3 2024 Earnings Release |
| 07/11/2023 10:30 | Q2 2024 Earnings Call |
| 07/11/2023 06:37 | Q2 2024 Earnings Release |
| 24/09/2023 | J.P. Morgan India Investor Summit |
| 19/09/2023 | RoadShow - Day 3 |
| 18/09/2023 | RoadShow - Day 2 |
| 17/09/2023 | RoadShow - Day 1 |
| 04/09/2023 | Ashwamedh Elara India Dialogue Conference |
| 30/08/2023 12:00 | Parkinson Disease and Movement Disorders International Congress - Abstract No : 1346 |
| 16/08/2023 | Avendus Spark Investor Conference |
| 11/08/2023 10:30 | Q1 2024 Earnings Call |
| 11/08/2023 08:01 | Q1 2024 Earnings Release |
| 11/08/2023 05:30 | Annual General Meeting |
| 27/07/2023 | Ex-dividend day for final dividend |
| 29/06/2023 | IIFL Investor Day |
| 06/06/2023 | Morgan Stanley India Investment Forum |
Past dividends on Zydus Lifesciences Limited
| 27/07/2023 | Annual 6 INR |
| 27/07/2022 | Annual 2.5 INR |
| 27/07/2021 | Annual 3.5 INR |
| 22/03/2020 | Interim Payment 3.5 INR |
| 24/07/2019 | Annual 3.5 INR |
| 30/07/2018 | Annual 3.5 INR |
| 15/03/2017 | Interim Payment 3.2 INR |
| 16/03/2016 | Interim Payment 3.2 INR |
| 29/07/2015 | Annual 12 INR |
| 16/07/2014 | Annual 9 INR |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 131 656 127 540 3.23% | 142 531 140 887 1.17% | 151 022 150 923 0.07% | 152 652 153 664 -0.66% | 172 374 169 393 1.76% | 192 760 |
|
EBITDA Million INR | Released Forecast Spread | 29 731 29 166 1.94% | 27 392 26 798 2.22% | 33 410 32 890 1.58% | 33 407 33 364 0.13% | 35 755 36 024 -0.75% | 51 577 |
|
EBIT Million INR | Released Forecast Spread | 23 745 23 098 2.8% | 20 427 19 546 4.51% | 26 162 25 039 4.48% | 26 277 25 526 2.94% | 31 372 28 631 9.57% | 44 151 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 23 821 24 002 -0.75% | 14 954 16 149 -7.4% | 22 848 23 858 -4.23% | 28 381 31 073 -8.66% | 25 897 29 128 -11.09% | 45 696 |
|
Net income Million INR | Released Forecast Spread | 18 488 18 530 -0.23% | 11 766 11 711 0.47% | 21 336 19 068 11.89% | 44 873 30 893 45.25% | 19 603 22 553 -13.08% | 35 800 |
|
EPS INR | Released Forecast Spread | 18,1 17,8 1.31% | 11,5 11,7 -1.71% | 20,8 19,1 9.11% | 43,8 29,7 47.43% | 19,3 22,3 -13.38% | 35,8 |
| Announcement Date | 29/05/19 | 19/06/20 | 27/05/21 | 20/05/22 | 18/05/23 | - |
Quarterly results
| Fiscal Period | March | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 38 467 38 264 0.53% | 40 254 38 599 4.29% | 37 848 37 304 1.46% | 36 550 37 614 -2.83% | 38 638 38 729 -0.23% | 40 727 39 749 2.46% | 41 347 40 671 1.66% | 43 623 41 565 4.95% | 50 106 46 625 7.47% | 51 396 49 552 3.72% | 46 971 | 44 460 | 53 450 |
|
EBITDA Million INR | Released Forecast Spread | 8 553 8 165 4.75% | 9 330 9 047 3.13% | 8 608 8 248 4.36% | 8 741 7 997 9.3% | 7 177 8 225 -12.74% | 8 301 8 267 0.41% | 8 153 8 411 -3.07% | 9 560 8 850 8.02% | 13 141 10 711 22.69% | 15 324 12 242 25.18% | 11 495 | 10 414 | 15 357 |
|
EBIT Million INR | Released Forecast Spread | 6 667 5 952 12.01% | 7 503 7 347 2.12% | 6 760 6 698 0.93% | 6 909 5 814 18.83% | 5 323 7 039 -24.38% | 6 523 6 430 1.45% | 6 335 6 800 -6.84% | 7 744 7 332 5.62% | 10 770 8 719 23.52% | 13 526 11 263 20.09% | 10 542 | 8 150 | 13 313 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 7 546 7 427 1.6% | 32 890 36 028 -8.71% | 5 990 5 926 1.08% | 5 729 6 808 -15.84% | 6 810 6 526 4.35% | 6 428 6 443 -0.24% | 7 801 6 861 13.71% | 4 858 8 775 -44.64% | 13 292 11 398 16.62% | 10 296 | 9 038 | 12 639 | |
|
Net income Million INR | Released Forecast Spread | 6 790 4 828 40.63% | 5 872 5 473 7.29% | 30 023 17 131 75.26% | 5 004 4 604 8.69% | 3 974 5 203 -23.62% | 5 183 5 327 -2.7% | 5 225 5 108 2.29% | 6 229 5 442 14.47% | 2 966 6 947 -57.3% | 10 869 8 387 29.6% | 7 846 | 6 895 | 9 689 |
|
EPS INR | Released Forecast Spread | 4,89 4,15 17.83% | 3,88 3,30 17.58% | 5,15 4,60 11.96% | 6,15 5,05 21.78% | 2,93 8,40 -65.12% | 8,90 | 7,69 | 8,49 | |||||
| Announcement Date | 27/05/21 | 11/08/21 | 29/10/21 | 03/02/22 | 20/05/22 | 10/08/22 | 11/11/22 | 03/02/23 | 18/05/23 | 11/08/23 | - | - | - |
More events
Past sector events for Zydus Lifesciences Limited
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ZYDUSLIFE Stock
- Calendar Zydus Lifesciences Limited
